| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...998069T |
| P356 | DOI | 10.1371/JOURNAL.PONE.0098069 |
| P8608 | Fatcat ID | release_t4pwuyjuwfagtgfcx2v4zjokfm |
| P932 | PMC publication ID | 4029819 |
| P698 | PubMed publication ID | 24849812 |
| P5875 | ResearchGate publication ID | 262537001 |
| P50 | author | Lars A. Akslen | Q11983239 |
| Mari K Halle | Q57518129 | ||
| Antoni Hurtado | Q58001222 | ||
| Henrica M J Werner | Q114341798 | ||
| Helga Salvesen | Q27506003 | ||
| Camilla Krakstad | Q38297664 | ||
| Jone Trovik | Q42385777 | ||
| P2093 | author name string | Kjell Petersen | |
| Kanthida Kusonmano | |||
| Anne M Oyan | |||
| Ingvild Løberg Tangen | |||
| Karl Henning Kalland | |||
| P2860 | cites work | Differential oestrogen receptor binding is associated with clinical outcome in breast cancer | Q24595511 |
| An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. | Q52171757 | ||
| FOXA1 Expression in Breast Cancer Correlation with Luminal Subtype A and Survival | Q59565516 | ||
| Estrogen Regulation of Epidermal Growth Factor Receptor Messenger Ribonucleic Acid | Q68456006 | ||
| Estrogen regulates the synthesis of epidermal growth factor in mouse uterine epithelial cells | Q68791159 | ||
| Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer | Q83223369 | ||
| High-level expression of forkhead-box protein A1 in metastatic prostate cancer | Q83606491 | ||
| Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer | Q85067190 | ||
| FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription | Q24645118 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 | Q28260929 | ||
| Integrated genomic characterization of endometrial carcinoma | Q28289962 | ||
| The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease | Q29547614 | ||
| Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4 | Q29618736 | ||
| Mechanisms of action of cyclosporine. | Q33908049 | ||
| Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer | Q34216102 | ||
| Withaferin A is a potent inhibitor of angiogenesis | Q34363498 | ||
| FOXA1 is a key determinant of estrogen receptor function and endocrine response | Q34508204 | ||
| FOXA1: master of steroid receptor function in cancer | Q35532767 | ||
| Prognostic parameters of endometrial carcinoma | Q35799482 | ||
| Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome | Q35949565 | ||
| FOXA1 mediates p16(INK4a) activation during cellular senescence | Q36706114 | ||
| Androgen receptor-independent function of FoxA1 in prostate cancer metastasis | Q36941029 | ||
| Unique ERalpha cistromes control cell type-specific gene regulation | Q36971843 | ||
| Markers for individualised therapy in endometrial carcinoma | Q38030768 | ||
| Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells. | Q39400129 | ||
| Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus | Q41398204 | ||
| FOXA1 is an independent prognostic marker for ER-positive breast cancer. | Q42486962 | ||
| FOXA1 promotes tumor progression in prostate cancer and represents a novel hallmark of castration-resistant prostate cancer | Q43581860 | ||
| Estrogen induces insulin-like growth factor-I expression in the rat uterus | Q44219242 | ||
| Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma | Q46950736 | ||
| Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer | Q47856838 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endometrial cancer | Q944777 |
| P304 | page(s) | e98069 | |
| P577 | publication date | 2014-05-21 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Switch in FOXA1 status associates with endometrial cancer progression | |
| P478 | volume | 9 |
| Q47448610 | Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions |
| Q38788210 | Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences |
| Q47657048 | FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy |
| Q40329034 | FOXA1 in HPV associated carcinomas: Its expression in carcinomas of the head and neck and of the uterine cervix |
| Q58738574 | FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome |
| Q37379842 | FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer |
| Q91588752 | Longitudinal analysis of epigenome-wide DNA methylation reveals novel smoking-related loci in African Americans |
| Q38917972 | The Estrogen Receptor α-Cistrome Beyond Breast Cancer. |
| Q42716517 | The mutational spectrum of FOXA2 in endometrioid endometrial cancer points to a tumor suppressor role. |
| Q26779980 | Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update |
Search more.